ÂÜÀòÂÒÂ×

Ilya Kuntsevich is an experienced financial executive currently serving as Chief Financial Officer at KopenTech and CRI Genetics, roles held since January 2023 and January 2021, respectively. Before these positions, Ilya was the Managing Partner at Beverly Investment Group from August 2011 to January 2021 and held various financial roles including Controller at Aurora Capital Group and Corporate Controller at EWT, LLC. Early in Ilya's career, tenure included senior management positions at Ernst & Young and Arthur Andersen, focusing on banking, investment analysis, and financial risk management. Ilya's educational background includes an MBA in Finance and Advanced International Management from UCLA Anderson School of Management and a Bachelor's degree in Economics from Finance University under the Government of the Russian Federation.